Compare Levi Strauss & Co. (LEVI) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Levi Strauss & Co. vs Health Care Select Sector SPDR Fund — how do they compare? Levi Strauss & Co. trades at $22.73 (market cap $8.75B), while Health Care Select Sector SPDR Fund trades at $167.38. The key difference: Levi Strauss & Co. pays a 2.81% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Levi Strauss & Co. nearer its low. Which is the better fit depends on your goals.
| LEVI | XLV | |
|---|---|---|
Market Cap | $8.75B | — |
Sector | Consumer Cyclical | — |
52-Week High | $25.53 | $168.44 |
52-Week Low | $17.92 | $131.16 |
Enterprise Value | $10.07B | — |
Dividend Yield | 2.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Levi Strauss & Co.
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
